CFO of Arrowhead Pharmaceuticals Inc (30-Year Financial, Insider Trades) Kenneth Allen Myszkowski (insider trades) sold 29,166 shares of ARWR on 10/20/2020 at an average price of $54.04 a share. The total sale was $1.6 million.
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins. Arrowhead Pharmaceuticals Inc has a market cap of $5.99 billion; its shares were traded at around $58.56 with and P/S ratio of 47.53. GuruFocus has detected 2 severe warning signs with Arrowhead Pharmaceuticals Inc. .
CFO Recent Trades:
- CFO Kenneth Allen Myszkowski sold 29,166 shares of ARWR stock on 10/20/2020 at the average price of $54.04. The price of the stock has increased by 8.36% since.
Directors and Officers Recent Trades:
- Director Mauro Ferrari sold 10,000 shares of ARWR stock on 10/09/2020 at the average price of $48. The price of the stock has increased by 22% since.
For the complete insider trading history of ARWR, click here
.
